Neck Residue of Nasopharyngeal Carcinoma (NPC): Timing of Diagnosis and Treatment


  • Ferucha Moulanda Department of Otorhinolaryngology Head and Neck Surgery, Faculty of Medicine Universitas Indonesia-Cipto Mangunkusumo General Hospital, Jakarta, Indonesia
  • Marlinda Adham Department of Otorhinolaryngology Head and Neck Surgery, Faculty of Medicine Universitas Indonesia-Cipto Mangunkusumo General Hospital, Jakarta, Indonesia



Adjuvant chemotherapy, nasopharyngeal carcinoma, neck dissection, neck residue



Prognosis of patients with NPC has improved but the risk of persistence regional of disease is still a critical problem. Timing of diagnosis the condition along with immediate yet appropriate treatment should be considered.

Case report:

Female 35 year-old diagnosed with NPC T2N3M0 and had finished neo-adjuvant chemotherapy (NAC) continued with chemoradiation (CRT) from July until December 2020. Clinical follow up on January 2021 showed palpable and fixated lymph node at level V of right neck sized 3x3x2.5 yet no mass identified at nasopharynx area. Patient was clinically diagnosed as neck residue of NPC and further management choices between early neck dissections or adjuvant chemotherapy (AdjCT) was still debatable in the multidisciplinary team discussion. 


Neck residue diagnosis for high risk features of NPC should be made early. Immediate appropriate treatment should be considered since its associated with prognosis and overall survival of NPC patient


Download data is not yet available.


Liu, S. L., Tang, L. Q., Chen, Q. Y., Lin, H. X., Yang, Q., Zhu, Q., Wen, W., Guo, S. S., Liu, L. T., Li, Y., Xie, H. J., Tang, Q. N., Sun, X. S., Liang, Y. J., Li, X. Y., Yan, J. J., Lin, C., Lan, X. W., Mai, H. Q., & Guo, L. The prognosis of neck residue nasopharyngeal carcinoma (NPC) patients: results from a case-cohort study. Journal of Cancer, Apr 2018. 9(10), 1765–1772. DOI:

Wang M, Xu Y, Chen X, Chen H, Gong H, Chen S. Prognostic significance of residual or recurrent lymph nodes in the neck for patients with nasopharyngeal carcinoma after radiotherapy. Journal of Cancer Research and Therapeutics. Jul 2016; 12:909-914. DOI:

Tsang RKY, Chung JCK, Ng YW, Howe VS, Ho ACW, Chan JYW, Ho WK, Wei WI. Efficacy of neck dissection for locoregional failures versus isolated nodal failures in NPC. Head and neck. 2012; 34:638-642. DOI:

Colevas, A. D., Yom, S. S., Pfister, D. G., Spencer, S., Adelstein, D., Adkins, D, Darlow, S. D. NCCN guidelines insights: head and neck cancers, version 1.2018. Journal of the National Comprehensive Cancer Network, 2018. 16(5), 479-490. DOI:

Liu YC, Wang WY, Twu CW, Jiang RS, Liang KL, Wu CT et al. Prognostic impact of adjuvant chemotherapy in high-risk NPC patients. Oral oncology. 2017; 64:15-21. DOI:

Wei WI, Mok VWK. The management of neck metastases in nasopharyngeal cancer. Current Opinion in Otolaryngology and Head and Neck Surgery. 2007;99-102. DOI:

Simo R, Robinson M, Lei M, Sibtain A, Hickey S. Nasopharyngeal carcinoma: United Kingdom National Multidisciplinary Guidelines. Journal of Laryngology and Otology.2016;130: S97-S103. DOI:

Liu YP, Li H, You R, Li JB, Liu XK, Yang AK, et al. Surgery for isolated regional failure in NPC after radiation: selective or comprehensive neck dissection. Laryngoscope. 2019; 129:387-395. DOI:

Xia L, Zeng Z, Guo Z, Guo G, Zhang B, Qiu H, Zhou F. Neck dissection for recurrent and persistent lymph nodes of nasopharyngeal carcinoma after radiotherapy: effect and choice. Chinese-German Journal of clinical oncology. 2009; 8:81-85. DOI:

Wang, SY, Lou, JL., Chen, J., Zhang, SZ., & Guo, L. Salvage surgery for neck residue or recurrence of nasopharyngeal carcinoma after primary radiotherapy: options of surgical methods and regions. World journal of surgical oncology, 2016. 14(1), 1-6. DOI:

Liang ZG, Zhang F, Yu BB, Li L, Qu S, Li Y, Guan Y, Liang RB, Han L, Zhu XD. The Double-Edge Role of the Addition of Adjuvant Chemotherapy to Concurrent Chemoradiotherapy in the Treatment of Nasopharyngeal Carcinoma. Cancer Manag Res. Feb 2020; 12:801-812. DOI:

Feng Y, Cao C, Hu Q, Chen X. Prognostic Value and Staging Classification of Lymph Nodal Necrosis in Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy. Cancer Res Treat. Jul 2019;51(3):1222-1230. DOI:

Xu T, Shen C, Ou X, He X, Ying H, Hu C. The role of adjuvant chemotherapy in nasopharyngeal carcinoma with bulky neck lymph nodes in the era of IMRT. Oncotarget. Apr 2016 12;7(15):21013-22. DOI:

Chen J, Liu T, Sun Q, Hu F. Clinical and prognostic analyses of 110 patients with N3 nasopharyngeal carcinoma. Medicine (Baltimore). Dec 2018; 97(49):e13483. DOI:

Zhang S, Zhou L, Huang X, Lin S. A retrospective study of concurrent chemoradiotherapy plus S-1 adjuvant chemotherapy on curative effect for treatment of patients with N3 stage nasopharyngeal carcinoma. Cancer Manag Res. Jun 2018 25; 10:1705-1711. DOI:

Yeung DCM, Yeung Z, Wong EWY, Vlantis AC, Chan JYK. Neck lymph node status on survival of regionally recurrent or persistent NPC. Natureresearch. 2020;10: 1-7. DOI:



How to Cite

Moulanda F, Adham M. Neck Residue of Nasopharyngeal Carcinoma (NPC): Timing of Diagnosis and Treatment. IJNPC [Internet]. 2021Mar.20 [cited 2021May11];3(01):17-9. Available from: